Ani Pharmaceuticals (ANIP) EPS (Basic) Growth (1y) (2012 - 2026)
Ani Pharmaceuticals (ANIP) EPS (Basic) Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | -301.82% |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 1.21% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -17.09% |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | 13.91% |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | -2,504.14% |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 31.67% |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | 388.06% |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | - |
| 10 | Ani Pharmaceuticals | 1.63 Bn | 1.27 Bn | 165.89 Mn | 184.35% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 184.35% |
| Mar 31, 2026 | 81.01% |
| Dec 31, 2025 | 347.92% |
| Sep 30, 2025 | 203.35% |
| Jun 30, 2025 | 394.41% |
| Mar 31, 2025 | -16.41% |
| Dec 31, 2024 | -1,428.94% |
| Sep 30, 2024 | -350.81% |
| Jun 30, 2024 | -142.25% |
| Mar 31, 2024 | 1,378.99% |
| Dec 31, 2023 | 114.55% |
| Sep 30, 2023 | 191.40% |
| Jun 30, 2023 | 135.03% |
| Mar 31, 2023 | 104.95% |
| Dec 31, 2022 | 85.19% |
| Sep 30, 2022 | -50.40% |
| Jun 30, 2022 | 19.29% |
| Mar 31, 2022 | -18,958.75% |
| Dec 31, 2021 | -535.64% |
| Sep 30, 2021 | -1,051.27% |